The Cleveland Clinic AI Playbook: What Enterprise Buyers Should Copy Before Funding a Single Model

The most mature enterprise AI use cases in healthcare today are ambient documentation that drafts clinical notes during the visit, and real-time clinical risk prediction such as AI sepsis detection. Cleveland Clinic runs both in production, backed by named vendor partnerships and a Chief AI Officer who owns strategy, safety, and governance across 23 hospitals.

That opening matters because most AI coverage in healthcare traffics in possibility. Cleveland Clinic traffics in deployment. The health system employs 83,000 caregivers, recorded 15.9 million patient encounters in 2025, and reported $18.3 billion in operating revenue, according to its own figures. When an organization that size moves AI out of the lab and into the exam room, the interesting question stops being “what can AI do” and becomes “how did they decide what to fund, and what should you copy.”

Why did Cleveland Clinic make AI an enterprise priority instead of a pilot?

Cleveland Clinic appointed its first Chief AI Officer in 2024 to lead enterprise AI strategy, safety, and governance, and in the 2026 State of the Clinic address CEO Dr. Tom Mihaljevic named staffing, scheduling, supply chain, clinical risk prediction, and paperwork automation as the targets. That ordering is the signal. The organization did not frame AI as a technology to adopt; it framed AI as a set of specific operational problems to relieve.

The practical difference shows up in who is accountable. A pilot reports to an innovation team and dies quietly when the champion changes jobs. An enterprise priority reports to a named executive with a mandate across the whole system, which is why Cleveland Clinic’s AI commitments survive long enough to reach thousands of users. If you are a buyer wondering whether your own AI effort is real or theater, the fastest test is whether one accountable person owns the outcome across the whole business.

How does ambient AI documentation cut after-hours charting?

Ambient AI listens to a patient visit in the background, with consent, and automatically drafts the structured clinical note inside the electronic health record so the clinician reviews and edits rather than types from scratch. Cleveland Clinic adopted Ambience Healthcare’s platform for exactly this, generating notes directly in Epic along with point-of-care coding and after-visit summaries.

The problem it attacks is expensive and well documented. In the American Medical Association’s 2025 survey of nearly 19,000 physicians, 41.9% reported at least one symptom of burnout, with ineffective EHR systems and administrative load among the leading causes. The AMA’s 2024 data found 22.5% of physicians spent more than eight hours a week on the EHR outside working hours. Across 14.4 million outpatient encounters, even two minutes per visit compounds into a capacity and retention problem.

The results Cleveland Clinic reports are concrete, if self-reported. Enterprise rollout began March 10, 2025 and reached more than 4,000 clinicians in about four months. A peer-reviewed npj Health Systems paper reports more than 4,800 clinicians across over 3.5 million encounters roughly a year in, with 70% encounter-level utilization among established users and 60% of users agreeing the tool increased their likelihood of staying in practice. Cleveland Clinic’s own Consult QD cites roughly 14 minutes saved per clinician per day, and pilot-stage figures from Fierce Healthcare included a 49.6% drop in after-hours documentation time. Two honest caveats: half the paper’s authors are Ambience employees with disclosed equity, and the retention number measures stated intent, not actual turnover. For any team drowning in manual documentation, AI embedded directly into the workflow rather than bolted on as a separate app is the pattern that earned adoption here.

How does AI sepsis detection work in production?

AI sepsis detection reads the full patient record continuously — labs, vital signs, clinical notes — in real time to score each patient’s risk, rather than running episodic rules-based checks. Cleveland Clinic deployed Bayesian Health’s platform for this, with an Enterprise Sepsis Steering Committee chaired by James Morrison, MD, governing how alerts enter clinical care.

Speed is the whole game. The Association of American Medical Colleges ranks sepsis as the third leading cause of death in U.S. hospitals and notes each hour of treatment delay raises the risk of death by 4% to 9%. The catch is that legacy tools were both inaccurate and noisy: a 2021 JAMA Internal Medicine validation of a widely used proprietary sepsis model at Michigan Medicine found it missed 67% of sepsis patients while firing alerts on 18% of all hospitalized patients. Alert fatigue destroys the trust a model needs to work.

Cleveland Clinic’s Fairview Hospital pilot covered more than 3,330 patients across 2024 and 2025 and reported, against legacy tools, a tenfold decrease in false alerts, a 46% increase in identified sepsis cases, and a sevenfold rise in cases flagged before antibiotics were given. These are single-hospital, self-reported results, not peer-reviewed. The underlying model builds on the TREWS system studied across five hospitals and 590,736 patients in a 2022 Nature Medicine paper, which found that when clinicians confirmed an alert within three hours, in-hospital mortality fell 3.3 percentage points — an 18.7% relative reduction. The lead author is affiliated with Bayesian, so the evidence is peer-reviewed but not independent. The platform received FDA 510(k) clearance in May 2026. The buyer’s lesson sits in that three-hour window: a model that finds more cases but floods teams with alerts can deliver less real value than its sensitivity score implies, so track false-alert rates and time-to-action, not just accuracy.

What is the repeatable pattern behind both use cases?

Strip away the clinical specifics and both projects follow an identical shape: one narrow, measurable problem, one named partner chosen through evidence, and a rollout sequenced to protect adoption. Cleveland Clinic did not buy “AI for healthcare.” It bought documentation relief and earlier sepsis detection — two problems with a clear before-and-after metric.

The selection method is worth stealing outright. Rather than running a traditional RFP, Cleveland Clinic ran a head-to-head evaluation of five ambient scribe vendors throughout 2024, scoring each on documentation quality, provider satisfaction, ease of implementation, and return on investment before awarding Ambience a five-year exclusive partnership. Chief Digital Officer Rohit Chandra frames the broader strategy as “partner if you can, build if you must,” and describes AI vendor selection as closer to buying into a company than buying a finished product — because the field is early enough that few vendors have a finished offering. He names change management, not technology, as the harder problem.

The rollout also respected where the tool was weak. Cleveland Clinic sequenced ambient AI by workflow complexity: pilot users first, then primary care, then selected specialties, with the most complex specialties last while the model improved. Adoption varied sharply — nephrology hit 99% while urology sat at 55% — proof that an enterprise average can hide specialties where a tool simply is not ready. Forcing an immature tool on skeptical users is how good AI projects die.

Should you build custom AI or buy an off-the-shelf tool?

Buy or partner when a mature vendor already solves your exact problem and the value is in your data and workflow, not in owning the model — Cleveland Clinic’s “partner if you can” rule. Build custom when the capability is a competitive differentiator, when your data or compliance requirements are unique, or when integration into proprietary systems is the hard part that no vendor will own for you.

Here is the honest version for a non-healthcare enterprise. If you run a logistics firm and need demand forecasting that dozens of vendors already offer, buying is faster and cheaper, and the risk is low. If you run a specialized operation where the AI touches a proprietary process, a bought tool will force your business to bend around its assumptions — and the cost of change later usually dwarfs the license savings today. We lay out that tradeoff in detail in this comparison of custom AI versus off-the-shelf SaaS AI. If you cannot name a single metric the project should move, or no one owns the outcome, stop — you are not ready to buy or build.

The translation to a non-healthcare enterprise is direct. Pick one narrow process with a measurable cost — claims triage, support ticket drafting, fraud scoring. Run a short competitive pilot with defined success criteria instead of a paper RFP. Judge winners on signal quality and user adoption, not demo polish. And wire the result into the systems your people already use, which is almost always a custom integration problem rather than a model problem. Within two years, the enterprises that win with AI won’t be the ones that bought the most capable model, but the ones that governed it like Cleveland Clinic did — narrow scope, named owner, measured relief.

FAQ

Q: What are the most proven enterprise AI use cases in healthcare? A: The two most deployment-ready are ambient AI documentation, which drafts clinical notes from the patient conversation to cut charting time, and AI clinical risk prediction such as sepsis detection, which reads the patient record in real time to flag risk earlier. Cleveland Clinic runs both in production across multiple hospitals with named vendor partners.

Q: Does an enterprise need a Chief AI Officer to succeed with AI? A: Not necessarily the exact title, but the function matters. Cleveland Clinic appointed its first Chief AI Officer in 2024 to own AI strategy, safety, and governance enterprise-wide. The underlying principle — one accountable executive owning outcomes, safety, and vendor decisions across the business — is what separates a scaling program from a stranded pilot.

Q: How did Cleveland Clinic choose its AI vendors? A: It ran competitive pilots instead of traditional RFPs. For ambient documentation, it tested five scribe vendors throughout 2024, scoring each on documentation quality, provider satisfaction, ease of implementation, and ROI, before awarding Ambience Healthcare a five-year exclusive partnership.

Key Takeaways

• Scope AI as a specific, measurable problem — documentation hours, false-alert volume — not as a technology to adopt; projects with a clear before-and-after metric are the ones that reach production.
• Replace the paper RFP with a short competitive pilot against defined criteria; evidence from real users de-risks a multiyear commitment far better than vendor demos.
• Judge clinical and operational AI on signal quality and adoption, not just headline accuracy — a model that floods users with false alerts erodes the trust its ROI depends on.
• Name one accountable owner for AI outcomes, safety, and governance before funding any build; without that, you are not ready to buy or build.
• Default to partnering where a mature vendor fits, and reserve custom builds for capabilities that differentiate you or require proprietary data and integration no vendor will own.